Vitreous biopsy, a minimally invasive procedure, is gaining traction in cancer research for its potential in diagnosing ocular malignancies. By extracting a small sample of the vitreous humor—the gel-like substance within the eye—researchers can identify cancerous cells or genetic material shed from tumors in the eye. This technique offers several advantages, including its low risk, ability to provide real-time molecular information, and its potential to guide personalized treatment strategies. Moreover, vitreous biopsy presents an opportunity for early cancer detection, crucial for improving patient outcomes. As technology advances, refining the sensitivity and specificity of vitreous biopsy could revolutionize ocular oncology, offering new insights into tumor biology and facilitating targeted therapies for eye cancers.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States